Pfizer CEO received his second dose of ‘Pfizer/BioNTech’ COVID-19 vaccine in March 2021

A post is being widely shared on social media claiming that Pfizer CEO has not been fully vaccinated. The post even claims that the CEO of Pfizer had to cancel a planned trip to Israel because he was not fully vaccinated. Let us fact-check the claim made in the post.

The archived version of the post can be seen here.

Claim: CEO of Pfizer is not fully vaccinated and had to cancel his trip to Israel.

Fact: The CEO of Pfizer, Albert Bourla, was fully vaccinated in March 2021. He received the second dose of the ‘Pfizer/BioNTech’ COVID-19 vaccine in the month of March 2021 itself. The news of Albert Bourla’s Israel visit cancellation for not being fully vaccinated was published prior to this in early March 2021. In an interview to CNBC Television in December 2020 when asked about vaccine hesitancy, Pfizer CEO Albert Bourla replied that one needs to ‘trust science’. Hence, the claim made in the post is FALSE.

When we searched on the internet regarding Pfizer CEO’s vaccination, a tweet by the CEO was found. Pfizer CEO Albert Bourla’s official Twitter account made this tweet on 11 March 2021 confirming that he had received his second dose of vaccination. According to the tweet, the CEO of Pfizer had received the second dose of the ‘Pfizer/BioNTech’ COVID-19 vaccine in the month of March 2021 itself. There was news (07 March 2021) back in early March when Albert Bourla’s Israel visit was cancelled because he was not fully vaccinated but this was before he took his second dose of vaccination.

In an interview with CNBC Television in December 2020, when asked about vaccine hesitancy, Pfizer CEO Albert Bourla replied that one needs to ‘trust science’. He even said that he would wait his turn to receive the vaccine after frontline workers and seniors had a chance. He received his second shot of the vaccine in March 2021, according to his Twitter account.

To sum it up, Pfizer CEO received his second dose of ‘Pfizer/BioNTech’ COVID-19 vaccine in March 2021.